1h Free Analyst Time
The injection pen market is forecasted to grow by USD 25.51 bn during 2023-2028, accelerating at a CAGR of 8.13% during the forecast period. The report on the injection pen market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of chronic diseases, the growing prevalence of diabetes cases, and the growing popularity of injectable therapies.
The injection pen market is segmented as below:
By Product
- Growth hormone
- Diabetes
- Fertility
- Osteoporosis
- Others
By Type
- Disposable injection pen
- Reusable injection pen
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the injection pen market covers the following areas:
- Injection pen market sizing
- Injection pen market forecast
- Injection pen market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global injection pen market: AstraZeneca Plc, Becton Dickinson and Co., Biocon Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gan and Lee Pharmaceuticals Co. Ltd., Gerresheimer AG, GlaxoSmithKline Plc, Harro Hofliger GmbH, Haselmeier GmbH, Jiangsu Delfu medical device Co. Ltd., Merck KGaA, Novartis AG, Novo Nordisk AS, Owen Mumford Ltd., Pfizer Inc., Sanofi, Solteam Electronics Co LTD., Viatris Inc., and Ypsomed Holding AG.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is significant rise in demand for insulin pens.'
According to the report, one of the major drivers for this market is the rising prevalence of chronic diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca Plc
- Becton Dickinson and Co.
- Biocon Ltd.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- Gan and Lee Pharmaceuticals Co. Ltd.
- Gerresheimer AG
- GlaxoSmithKline Plc
- Harro Hofliger GmbH
- Haselmeier GmbH
- Jiangsu Delfu medical device Co. Ltd.
- Merck KGaA
- Novartis AG
- Novo Nordisk AS
- Owen Mumford Ltd.
- Pfizer Inc.
- Sanofi
- Solteam Electronics Co LTD.
- Viatris Inc.
- Ypsomed Holding AG
